4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-12-001890
Options or other derivatives
- Director acquired 313,275 shares (grant or award)
- Director returned 514,800 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Dunkerley Hugh D P · Director
Table II: Derivative
7 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2012-12-21 | Returned to the company : show line 1 in the form Employee Stock Options (right to buy) | −30,000 | $1.50 | 2017-12-21 | 30,000 | 664,800 | D |
| 2012-12-21 | Returned to the company : show line 2 in the form Employee Stock Options (right to buy) | −80,000 | $1.50 | 2018-04-21 | 80,000 | 584,800 | D |
| 2012-12-21 | Returned to the company : show line 3 in the form Employee Stock Options (right to buy) | −127,400 | $1.55 | 2020-05-20 | 127,400 | 457,400 | D |
| 2012-12-21 | Returned to the company : show line 4 in the form Employee Stock Options (right to buy) | −127,400 | $1.55 | 2020-05-20 | 127,400 | 330,000 | D |
| 2012-12-21 | Returned to the company : show line 5 in the form Employee Stock Options (right to buy) | −75,000 | $1.55 | 2020-05-20 | 75,000 | 255,000 | D |
| 2012-12-21 | Returned to the company : show line 6 in the form Employee Stock Options (right to buy) | −75,000 | $1.54 | 2021-05-10 | 75,000 | 180,000 | D |
| 2012-12-21 | Grant or award : show line 7 in the form Employee Stock Options (right to buy) | +313,275 | $0.95 | 2022-09-15 | 313,275 | 493,275 | D |
Loading xslF345X03/form4-12212012_031221.xml…